NCT06927752View on ClinicalTrials.gov

Retrospective Data Analysis PelviGYNious/EndoGYNious

Active, not recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

August 31, 2025

Conditions
ProlapseSacrocolpopexyPelvic Organ Prolapse (POP)
Interventions
DEVICE

PelviGYNious

Patient received PelviGYNious implant.

DEVICE

EndoGYNious

Patient received EndoGYNious implant.

Trial Locations (1)

Unknown

Universitätsklinikum Erlangen, Frauenklinik, Erlangen

All Listed Sponsors
lead

A.M.I. Agency for Medical Innovations GmbH

INDUSTRY

NCT06927752 - Retrospective Data Analysis PelviGYNious/EndoGYNious | Biotech Hunter | Biotech Hunter